REGENXBIO Inc.
RGNX
DELAYED 1 MONTH

11 insider filings · Latest: May 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 11, 2026May 13 9:18 PMSteve PakolaChief Medical Officer
Sale
15,309$11.02$168.7K232,617(D)

View →

Mar 10, 2026Mar 12 10:17 PMSteve PakolaChief Medical Officer
Sale
5,124$10.35$53.0K247,926(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 29, 2026Jun 2 9:21 PMDaniel TasseDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:20 PMDavid C StumpDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:20 PMJennifer ZacharyDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:16 PMKenneth T. MillsDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:16 PMGeorge V MigauskyDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:16 PMArgeris N KarabelasDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:16 PMAlexandra GlucksmannDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:15 PMAllan M. FoxDirector
Grant/Award
46,600$7.0146,600(D)

View →

May 29, 2026Jun 2 9:15 PMJean BennettDirector
Grant/Award
46,600$7.0146,600(D)

View →